<?xml encoding="utf-8" ?> Sarepta Therapeutics SRPT reported third-quarter financial results on Thursday. The transcript from ...

Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track Angel Pharmaceuticals completes enrollment in ...

The Nikkei 225 fell 893 yen to 62,189 yen. It significantly narrowed its losses from an intraday low of 60,030 yen.👀 Despite ...

A continuous-wave laser study finds strong third-order nonlinear optical responses in MEH-PPV and PBDB-T polymer solutions, ...

November 2, 2026For those who want to organize radio engineering and radio laws through 100 four-choice questions with explanations for all optionsSome candidates for the Second-Class Land Special Rad ...

Long-range OCT imaging with machine learning segmentation shows that human accommodation is driven mainly by the lens nucleus ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations ...

Phase 3 ReDiscover-2 trial in 2L breast cancer expected to complete enrollment in mid-2027Updated data from ongoing Phase 1/2 ReInspire trial of ...

First patient completed observation period following PBGENE-DMD treatment with no reported safety concerns - - Independent Data Safety Monitoring Board endorses proceeding with dosing additional ...

A field demonstration on a 500-MW-class coal-fired unit shows how targeted fuel chemistry can mitigate severe slagging and fouling while delivering measurable operating benefits—including ...